What is Climb Bio, Inc.'s capex?

Climb Bio, Inc. (CLYM) reported capex of $109K in Q3 2025.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Climb Bio, Inc. CLYM CapEx

CapEx at other companies

Bristol-Myers SquibbBMY

$347M+33.5%

AmgenAMGN

$712M+73.2%

Vera TherapeuticsVERA

$23K-87.7%

Kyverna Therapeutics, Inc.KYTX

$2K-98.0%

Cullinan Therapeutics, Inc.CGEM

$11K—

Jade Biosciences, Inc. Common StockJBIO

$3K—

Other financials

Income statement

See full

Operating income-$15.2M+33.9%

Net income-$13.7M+34.0%

EPS (diluted)-$0.20+35.5%

Balance sheet

See full

Cash & equivalents$8.4M-71.2%

Total debt$479.0K+1.1%

Total equity$148.1M-23.4%

Total assets$152.4M-24.1%

Cash flow

See full

Operating cash flow-$14.4M+6.8%

Free cash flow-$15.6M-183%

Valuation

See full

Market cap$724.95M+787%

Enterprise value$717.07M+1,247%

Returns & leverage

See full

Return on equity-30.9%-10.3pp

Debt / equity0×0.0×

Current ratio27.9×+13.6×

Where this comes from

Reported directly by Climb Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Climb Bio, Inc.’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Climb Bio, Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Climb Bio, Inc.'s capex?: Climb Bio, Inc. (CLYM) reported capex of $109K in Q3 2025.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.